Ongoing studies but not recruiting participants
Phase III trials
This section of Clinical Trials Watch contains information about some clinical trials that are:
- Ongoing but not recruiting participants
- Conducted at least in one European country
- In phase III
In these ongoing studies listened below, participants are receiving an intervention or being examined but new potential participants are not currently being recruited.
| Study | Study sponsor | Name of the drug | Condition | Estimated end of the study |
| CREAD | Hoffmann-La Roche | Crenezumab | Prodromal to Mild Alzheimer's Disease | July 2021 |
| CREAD2 | Hoffmann-La Roche | Crenezumab | Prodromal to Mild Alzheimer's Disease | October 2022 |
| EMERGE | Biogen | Aducanumab (BIIB037) | Early Alzheimer's Disease | April 2022 |
| ENGAGE | Biogen | Aducanumab (BIIB037) | Early Alzheimer's Disease | April 2022 |
This table is a not exhaustive resource of information and could be downloaded as a pdf file below.
Please note that an accessible easy read version of each study is available as a pdf below. This pdf file includes more information on each study as well as the link to the full text.
Downloads
Last Updated: Thursday 07 February 2019
